joikhealth.com

What It Is

Joik Health Limited is a UK-registered provider of patient reimbursement solutions for clinical trials. Its core products are the Joik payment solution / Joik Card. The company aims to address the problem of patients becoming less willing to participate in studies—or dropping out midway—because they have to pay upfront for travel, accommodation, childcare, lost wages, and other expenses. It digitizes traditional cash and paper-receipt workflows through prepaid cards, a mobile app, and an online portal.

Core Capabilities

In terms of service offering, Joik targets sponsors, CROs, and research sites with tools for managing and reimbursing patient expenses. Payment methods include Mastercard prepaid cards, reloadable prepaid cards, and direct bank deposits in local currencies. According to the official website, the prepaid cards are accepted globally, and expenses can be reimbursed within minutes. Patients can submit expenses and view card transactions through a multilingual mobile app, while sites and sponsors can check status and download Excel/CSV reports via an online dashboard. On compliance, the company only discloses that it is registered in England and Wales and governed by English law; it does not disclose its payment license, card issuer, or electronic money partner.

Pricing and Transparency

The official website does not publish implementation fees, monthly fees, card fees, top-up fees, cross-border transaction fees, withdrawal fees, or bank deposit charges. It also does not explain how exchange rates are handled across different countries. As a result, it is difficult to directly assess total cost of ownership. Before procurement, buyers should request a quote, contract terms, and a detailed fee schedule.

Pros and Cons

The main advantage is that Joik is highly vertical: it is designed specifically around clinical trial patient reimbursement. It can reduce manual processing at research sites, improve reimbursement visibility, and enhance patient satisfaction and retention through faster payments. The drawbacks are also clear: key payment-infrastructure details are limited, including country coverage, compliance licensing, risk controls, KYC/AML, data security, and API integration. The website remains more at the level of solution introduction than full operational disclosure.

Who It’s For

Joik is better suited to sponsors, CROs, and research centers running clinical trials in Europe or across multiple countries that want to reduce cash reimbursement and paper-receipt workflows. If an organization needs a mature open API, clear global acquiring/card-issuing coverage, complete compliance disclosure, and a standardized price list, further due diligence will be necessary.

Access from China and Alternatives

Access from mainland China cannot be determined from the available text, so it should be marked as unknown. The service also does not state whether it supports reimbursement for patients in China or RMB settlement. For clinical trials conducted in China, it is advisable to also evaluate local banks, corporate payment platforms, or clinical trial patient payment providers with China-specific compliance capabilities.